OAK

Novel thioxothiazolo[3,4-a]quinazolin-5(4H)-one derivatives as BK(Ca) channel activators for urinary incontinence.

Metadata Downloads
Author(s)
Bae, Eun Jung; Jo, Heeji; Kim, Seong Soon; Shin, Dae-Seop; Yang, Jung Yoon; Bae, Myung Ae; Jeong, Pyeonghwa; Park, Chul-Seung; Ahn, Jin Hee
Type
Article
Citation
ACS Medicinal Chemistry Letters, v.13, no.7, pp.1052 - 1061
Issued Date
2022-06
Abstract
Overactive bladder (OAB) is a syndrome causing a sudden and unstoppable need to urinate with significant global prevalence. Several drugs are used to treat OAB; however, they have various side effects. Therefore, new treatment options for OAB are required. A series of novel 5-oxo-N-phenyl-1-thioxo-4,5-dihydro-1H-thiazolo[3,4-a]quinazoline-3-carboxamide derivatives were synthesized and evaluated for their large-conductance voltage-and Ca2+-activated K+ channel activation through a cell-based fluorescence assay and electrophysiological recordings. Several compounds, including a 7-bromo substituent on the heterocyclic system, showed increased channel currents. Among the derivatives, compound 12h exhibited potent in vitro activity with a half-maximal effective concentration (EC50) of 2.89 mu M, good oral pharmacokinetic properties (area under the curve and half-life), and in vivo efficacy in a spontaneously hypertensive rat model.
Publisher
Amer Chemical Soc
ISSN
1948-5875
DOI
10.1021/acsmedchemlett.2c00070
URI
https://scholar.gist.ac.kr/handle/local/10767
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.